Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Rhabdoid Tumor 1 Neuroectodermal Tumors, Primitive 1 Meningeal Carcinomatosis 1 Medulloblastoma 1 Lung Neoplasms 1 Infratentorial Neoplasms 1 Ependymoma 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 8 X-Rays 7 Phantoms, Imaging 7 Cyclophosphamide 7 Specimen Handling 6 Nuclear Medicine Department, Hospital 5 fludarabine 4 Etoposide 4 Biopsy 4 tazemetostat 3 etoposide phosphate 3 Vincristine 3 Temozolomide 3 Nivolumab 3 Cisplatin 3 Carboplatin 3 Automobiles 3 ulixertinib 2 tipifarnib 2 selpercatinib 2 palbociclib 2 larotrectinib 2 ivosidenib 2 erdafitinib 2 ensartinib 2 Topotecan 2 Sirolimus 2 Methotrexate 2 Mesna 2 LY3023414 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Rhabdoid Tumor × Craniospinal Irradiation × 1 year × Clear all

NCT02114229 2026-03-17

SJATRT

St. Jude Children's Research Hospital

Phase 2 Active not recruiting

Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡